Year |
Citation |
Score |
2023 |
André T, Berton D, Curigliano G, Sabatier R, Tinker AV, Oaknin A, Ellard S, de Braud F, Arkenau HT, Trigo J, Gravina A, Kristeleit R, Moreno V, Abdeddaim C, Vano YA, ... ... Dewal N, et al. Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial. Jama Network Open. 6: e2341165. PMID 37917058 DOI: 10.1001/jamanetworkopen.2023.41165 |
0.38 |
|
2022 |
Milbury CA, Creeden J, Yip WK, Smith DL, Pattani V, Maxwell K, Sawchyn B, Gjoerup O, Meng W, Skoletsky J, Concepcion AD, Tang Y, Bai X, Dewal N, Ma P, et al. Clinical and analytical validation of FoundationOne®CDx, a comprehensive genomic profiling assay for solid tumors. Plos One. 17: e0264138. PMID 35294956 DOI: 10.1371/journal.pone.0264138 |
0.485 |
|
2020 |
Wheeler DA, Takebe N, Hinoue T, Hoadley KA, Cardenas MF, Hamilton AM, Laird PW, Wang L, Johnson A, Dewal N, Miller V, Piñeyro D, Castro de Moura M, Esteller M, Shen H, et al. Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment. Cancer Cell. PMID 33217343 DOI: 10.1016/j.ccell.2020.10.015 |
0.489 |
|
2020 |
Woodhouse R, Li M, Hughes J, Delfosse D, Skoletsky J, Ma P, Meng W, Dewal N, Milbury C, Clark T, Donahue A, Stover D, Kennedy M, Dacpano-Komansky J, Burns C, et al. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. Plos One. 15: e0237802. PMID 32976510 DOI: 10.1371/journal.pone.0237802 |
0.602 |
|
2019 |
Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, Frampton GM, Bratslavsky G, Pal SK, Lee RJ, Necchi A, Gregg JP, Lara P, Antonarakis ES, Miller VA, et al. Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors. Jco Precision Oncology. 3. PMID 31218271 DOI: 10.1200/PO.18.00283 |
0.33 |
|
2016 |
Gingras MC, Covington KR, Chang DK, Donehower LA, Gill AJ, Ittmann MM, Creighton CJ, Johns AL, Shinbrot E, Dewal N, Fisher WE, Pilarsky C, Grützmann R, Overman MJ, et al. Ampullary Cancers Harbor the Tumor Suppressor Gene ELF3 and Exhibit Frequent WNT Dysregulation. Cell Reports. PMID 26804919 DOI: 10.1016/J.Celrep.2015.12.005 |
0.512 |
|
2010 |
LaFramboise T, Dewal N, Wilkins K, Pe'er I, Freedman ML. Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis. Plos Genetics. 6: e1001086. PMID 20824129 DOI: 10.1371/Journal.Pgen.1001086 |
0.691 |
|
2010 |
Dewal N, Freedman ML, LaFramboise T, Pe'er I. Power to detect selective allelic amplification in genome-wide scans of tumor data. Bioinformatics (Oxford, England). 26: 518-28. PMID 20031965 DOI: 10.1093/Bioinformatics/Btp694 |
0.703 |
|
Show low-probability matches. |